According to World Health Organization (WHO), around 50 million people worldwide have epilepsy, a neurological disorder characterised by recurrent seizures. It is also estimated that up to 70 per cent ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer and dementia, a sweeping ...